Monsanto (MON) Misses Q4 EPS by 17c; Guides FY15 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Global Portfolio, Leading Innovation and Financial Discipline Enabled Year of Solid Performance for Monsanto, Backing Confidence in Long-Term Growth Opportunity
October 7, 2015 8:02 AM EDTFY15 EPS of $5.73 on an ongoing basis and $4.81 on an as-reported basis With continuing industry headwinds, FY16 ongoing EPS guidance at $5.10 to $5.60; $4.44 to $5.01 on an as-reported basis as a result of forecasted charges related to announced restructuring actions Announces new $3 billion accelerated share repurchase program under its current share repurchase authorization, as it progresses toward its targeted capital structure Confirms five year plan to deliver more than double 2014 ongoing EPS by 2019, with more than 20 percent annual growth in ongoing EPS... More



